Stock Events

Stock Events

Zevra Therapeutics (1GDA.F) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.65

-0.45

-0.25

-0.05

Details

Expected EPS

-0.16213039727

Actual EPS

-0.0536178

Surprise EPS

0.11

Surprise Percent

+66.93%

Description

Zevra Therapeutics (1GDA.F) has reported earnings of -0.0536178 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.